Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. svnanovax

SVNanoVax SIGNED

Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 SVNanoVax project word cloud

Explore the words cloud of the SVNanoVax project. It provides you a very rough idea of what is the project "SVNanoVax" about.

bexsero    structure    vaccinology    diseases    functional    pace    structural    lives    scarselli    innovative    map    menb    disease    secondly    immunogenicity    nada    suitable    display    optimized    serogroup    candidates    pathogens    immunogenic    humans    termed    escape    variability    offers    3d    1st    monoclonal    2nd    meningitidis    vaccines    safe    structures    2013    stably    protein    infectious    2011    quality    invasive    promises    antigen    overcome    approved    bionanoparticles    protect    bionanoparticle    neisseria    epitopes    displaying    ordered    issue    sequence    bactericidal    2010    bnps    copy    2012    safety    delany    antibodies    million    protective    ryan    firstly    save    encompassing    aid    pioneered    malito    combine    generation    2014    assembling    probability    self    antigens    nanobiology    mapping    sepsis    career    bachmann    breadth    host    potentiate    reducing    expertise    opportunity    meningococcal    coverage    vaccine    broadly    enhanced    fhbp    bnp    generate    prepared    arrays    combines    epitope   

Project "SVNanoVax" data sheet

The following table provides information about the project.

Coordinator		 GLAXOSMITHKLINE VACCINES SRL 

Organization address
address: VIA FIORENTINA 1
city: SIENA
postcode: 53100
website: www.novartis.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Total cost 168˙277 €
 EC max contribution 168˙277 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-RI
 Starting year 2015
 Duration (year-month-day) from 2015-06-15   to  2017-06-14

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GLAXOSMITHKLINE VACCINES SRL IT (SIENA) coordinator 168˙277.00

Map

 Project objective

Vaccines are the most effective way to protect humans from infectious disease and may save over 2 million lives per year (Delany, 2013). A key issue for future vaccines is how to improve immunogenicity without reducing safety (Bachmann, 2010). Another challenge is that high antigen sequence variability enables pathogens to escape the host response. To overcome these challenges, this proposal combines Structural Vaccinology and bionanoparticle (BNP) design, to generate novel self-assembling BNPs with multi-copy antigen display for the development of safe vaccine antigens with enhanced immunogenicity and breadth of coverage.

We will generate antigen-BNPs for a 2nd generation vaccine against Neisseria meningitidis serogroup B (MenB), a major cause of sepsis and invasive disease (Pace, 2012). This research may also potentiate antigen-BNP technology suitable for other vaccines. Firstly, we will use functional (bactericidal) monoclonal antibodies to map the most protective epitopes on the 3D structures of two key MenB antigens, fHbp and NadA, which contribute strongly to our recently-approved 1st generation MenB vaccine, Bexsero (O’Ryan, 2014). To aid this, we have developed wide expertise in structure-focused epitope mapping (Malito, 2013). Secondly, we will design optimized antigens stably displaying the best epitopes, an approach that we have pioneered and termed ‘Structural Vaccinology’ (Scarselli, 2011). Finally, self-assembling protein bionanoparticles displaying ordered arrays of the optimized antigens will be prepared, in order to generate novel highly-immunogenic, broadly-protective MenB vaccine candidates.

The proposal offers an exciting career development opportunity encompassing novel high-quality research to combine and deliver the promises of Structural Vaccinology and nanobiology, with a high probability of success to generate innovative new vaccine antigens for products to protect humans against meningococcal and other infectious diseases.

 Publications

year authors and title journal last update
List of publications.
2016 Jacinto López-Sagaseta, Enrico Malito, Rino Rappuoli, Matthew J. Bottomley
Self-assembling protein nanoparticles in the design of vaccines
published pages: 58-68, ISSN: 2001-0370, DOI: 10.1016/j.csbj.2015.11.001 		Computational and Structural Biotechnology Journal 14 2019-06-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SVNANOVAX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SVNANOVAX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

TheaTheor (2018)

Theorizing the Production of 'Comedia Nueva': The Process of Play Configuration in Spanish Golden Age Theater

Read More  

EVOMET (2019)

The rise and fall of metastatic clones under immune attack

Read More  

GrowthDevStability (2020)

Characterization of the developmental mechanisms ensuring a robust symmetrical growth in the bilateral model organism Drosophila melanogaster

Read More